{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:29:41Z","timestamp":1747178981970,"version":"3.40.5"},"reference-count":45,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:00:00Z","timestamp":1661644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/14740338.2022.2115479","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:16:36Z","timestamp":1661750196000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Disease-specific ADRs of TNF-\u03b1 inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study"],"prefix":"10.1080","volume":"22","author":[{"given":"Lieke H.","family":"Roest","sequence":"first","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-2286","authenticated-orcid":false,"given":"Leanne J.","family":"Kosse","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"},{"name":"Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2303-6199","authenticated-orcid":false,"given":"Jette A.","family":"van Lint","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"},{"name":"Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen R.","family":"Gosselt","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joep H.G.","family":"Scholl","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-1398","authenticated-orcid":false,"given":"Eug\u00e8ne","family":"van Puijenbroek","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"},{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-7718","authenticated-orcid":false,"given":"Harald E.","family":"Vonkeman","sequence":"additional","affiliation":[{"name":"Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands"},{"name":"Department of Rheumatology & Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander W.","family":"Tas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Clinical Immunology, Amsterdam UMC, location AMC, University of Amsterdam and Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-1934","authenticated-orcid":false,"given":"Michael T.","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology & immunology Center | Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart J.F.","family":"van den Bemt","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-1259","authenticated-orcid":false,"given":"Naomi T.","family":"Jessurun","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, The Netherlands"},{"name":"Unit of Pharmacotherapy, Epidemiology & -Economics, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8,28]]},"reference":[{"key":"cit0001","unstructured":"Package leaflet: information for the patient; Humira 40 mg solution for injection in pre-filled pen; Adalimumab [Internet]. [cited 2021 Apr 22]. Available from 2021 Apr 22: https:\/\/www.medicines.org.uk\/emc\/files\/pil.272.pdf"},{"key":"cit0002","unstructured":"Package leaflet: information for the user enbrel 25 mg solution for injection in pre-filled syringe Enbrel 50 mg solution for injection in pre-filled syringe; etanercept [Internet]. [[cited 2021 Apr 22]. Available from: https:\/\/www.medicines.org.uk\/emc\/files\/pil.272.pdf"},{"key":"cit0003","unstructured":"Kirkham B, Furst DE, Romain PLR. Tumor necrosis factor-alpha inhibitors: an overview of adverse effects [Internet]. UpToDate. 2020 [cited 2021 Apr 22]. Available from: https:\/\/www-uptodate-com.proxy.library.uu.nl\/contents\/tumor-necrosis-factor-alpha-inhibitors-an-overview-of-adverse-effects"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1781090"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq207"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14776"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201244"},{"key":"cit0008","doi-asserted-by":"crossref","unstructured":"Baeten D, Van Hagen PM. Use of TNF blockers and other targeted therapies in rare refractory immune-mediated inflammatory diseases: evidence-based or rational? [Internet]. Ann. Rheum. Dis. Ann Rheum Dis; 2010 [cited 2021 May 6]. p. 2067\u20132073. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20705637\/","DOI":"10.1136\/ard.2009.126813"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1803826"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez412"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.014"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00946-z"},{"key":"cit0013","unstructured":"van Lint JA, Jessurun NT, Tas SW, et al. Gastrointestinal adverse drug reaction profile of etanercept: real world data from patients and healthcare professionals. J Rheumatol [Internet]. 2021 [cited 2021 Jun 20];201373. Available from: https:\/\/www.jrheum.org\/content\/early\/2021\/05\/11\/jrheum.201373"},{"key":"cit0014","doi-asserted-by":"crossref","unstructured":"Brown EG, Wood L, Wood S. The Medical Dictionary for Regulatory Activities (MEDDRA) [Internet]. Drug Saf. Drug Saf; 1999 [cited 2021 May 19]. p. 109\u2013117. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10082069\/","DOI":"10.2165\/00002018-199920020-00002"},{"key":"cit0015","unstructured":"Fisher R. Tests of significance in harmonic analysis. 1929 [cited 2021 May 19]; Available from: https:\/\/hekyll.services.adelaide.edu.au\/dspace\/bitstream\/2440\/15201\/1\/75.pdf"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"cit0017","first-page":"604","volume":"20","author":"Jafari M","year":"2019","journal-title":"Cell J"},{"key":"cit0018","first-page":"548","volume":"80","author":"Roest L","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/313858"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1007\/s11420-005-0133-z"},{"key":"cit0021","first-page":"495","volume":"63","author":"Wolfe F","year":"2004","journal-title":"Ann Rheum Dis - BMJ Publ Gr"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094730"},{"key":"cit0023","unstructured":"Akhondi H, Varacallo M. Rheumatoid arthritis and ankylosing spondylitis [Internet]. StatPearls. StatPearls Publishing; 2018 [cited 2021 Jul 5]. Available from 2021 Jul 5: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30335321"},{"key":"cit0024","volume":"27","author":"Inman RD","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq300"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12107"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.2174\/1573397116666200905122757"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0071-5"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.197"},{"issue":"12","key":"cit0030","first-page":"2563","volume":"30","author":"Furst DE","year":"2003","journal-title":"J Rheumatol"},{"issue":"7","key":"cit0031","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.40851","volume":"71","author":"Mease PJ","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15640-7"},{"key":"cit0033","first-page":"269","volume":"22","author":"Parakkal D","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"key":"cit0034","unstructured":"Gerriets V, Bansal P, Goyal A, et al. Tumor Necrosis Factor Inhibitors. StatPearls [Internet]. 2021 [cited 2021 Jul 18]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482425\/."},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00460"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.818531"},{"issue":"1","key":"cit0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02231-x","volume":"22","author":"Vela P","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1185-6"},{"key":"cit0039","unstructured":"Methotrexate 2.5 mg tablets - summary of product characteristics (smpc) - (emc) [internet]. Electron. Med. Compend. 2020 [cited 2022 May 26]. Available from 2022 May 26: https:\/\/www.medicines.org.uk\/emc\/product\/511\/smpc"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00965"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.013052"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.10.004"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04684-1"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.005"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.10.020"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2022.2115479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T09:48:08Z","timestamp":1681120088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2022.2115479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,28]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/14740338.2022.2115479"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2022.2115479","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2022,8,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}